Page 8 - Serum Institute Of India

Serum Institute's Adar Poonawalla appointed chairman of Magma Fincorp

Vijay Deshwal, currently with ICICI Bank as its business head, will take charge as CEO of Magma Fincorp in July

Will be able to manufacture, supply 100 mn Covishield doses in June: SII

Serum Institute of India (SII) has informed the government that it will be able to manufacture and supply nine to 100 million doses of Covishield in June

Shortage of transparency

Govt, companies must end opacity on vaccine supplies

ICMR to examine effectiveness of SII's Covishield, Bharat Biotech's Covaxin

The Indian Council of Medical Research (ICMR) will conduct a survey from next week to examine the effectiveness of these vaccines in preventing progression of COVID into a severe form.

India a dysfunctional anarchy?

It is the people who lost as the government scored self-goals

At current rate, India will vaccinate 75% population only by mid-2024

Asking rate in coming months is thrice the current vaccination rate, a tall order unless vaccine procurement is ramped up on a war footing

Delhi yet to receive more Covid-19 vaccines for 18-44 group, says Atishi

Delhi is yet to receive more vaccines for the 18-44 age group and only private hospitals are giving jabs to beneficiaries in this category for now, Aam Aadmi Party MLA Atishi said on Tuesday

Serum Institute disassociates from executive's remarks on Covid vaccination

Serum Institute has disassociated itself from its executive director's statement that govt began the Covid vaccination of multiple age groups without taking into consideration the available stock

India is world's vaccine factory: What happens when it can't deliver

India stopped exporting Covid-19 vaccines in mid-April, leaving low-income and lower-middle-income countries in the lurch.

SBI report pegs total Covid vaccination cost in India at Rs 3.7 trillion

Poorer states with high population would not be able to vaccinate themselves quickly. Richer states may have to pay a much steeper price given the global oligopolistic market, the report said

India's largest vial maker expects sales to triple on vaccine ramp up

Schott Kaisha is also in talks with Indian manufacturers of Russia's Sputnik V vaccine to supply millions of vials, but is yet to receive bulk orders

SII, Bharat Biotech to get bulk of Rs 15K-crore profit pool: Report

At present, SII sells its vaccine Covishield to the Centre for Rs 150 per dose, to state governments for Rs 300 and to private hospitals for Rs 600.

Mumbai receives import bids for Sputnik, preps for 60-day vaccination drive

Mumbai estimates to spend 7 billion rupees to buy shots informed municipal commissioner Iqbal Singh Chahal.

Covid-19 crisis: Over no response, states relax global vaccine tender norms

BMC was the first civic body in the country to float a global tender for purchasing vaccines

Serum Institute has to 'catch up', supply Covid-19 vaccines: WHO chief

"Once the devastating outbreak in India recedes, we also need the Serum Institute of India to get back on track and catch up on its delivery commitments to Covax," WHO chief said

Adar Poonawalla exits Panacea Biotec; sells entire stake for Rs 118 cr

Serum Institute of India CEO Adar Poonawalla offloaded his entire stake in Panacea Biotec amounting to 5.15 per cent shareholding of the firm for Rs 118 crore, through an open market transaction

The way forward for firms

Indian firms need to prepare for export boom by vaccinating employees, their family members; and prioritise export market

The vaccine gap

Timelines suggest govt must focus on health infra too

2 billion Covid-19 doses a long haul, but most will be covered by December

SII aims to make 50 million doses of Covovax (the Novavax vaccine) per month at its Pune plant

India's vaccine supplies to improve as it braces for Covid-19 third wave

India has vaccinated 37.2 million people with both doses of a vaccine, and about 135.5 million have received at least the first jab